Carbohydrates for life, health and diseases
What molecules determine human ABO blood groups? What do influenza viruses grab when they infect a human? What define the serotypes of bacterial species? What are the most diverse protein post-translational modifications? The answer to all of these questions is “carbohydrates.”
Indeed, carbohydrates are indispensable biomolecules and components that are essential for life. They are key recognition components of many biological and pathological events. Synthesizing glycans and understanding the roles of carbohydrates used to be daunting tasks but, thanks to recent progress, have become easier.
The exciting talks in our symposium at Discover BMB, the annual meeting of the American Society for Biochemistry and Molecular Biology, which will be held in March in Seattle, will present recent advances made on several fronts: glycan synthesis, tools developed, chemical biology, and the roles and the applications of carbohydrates in health and diseases.
The topics include human and bacterial glycans, biocatalysis, chemoenzymatic synthesis, glycomics, glycoproteomics, anti-glycan antibodies and the roles and applications in learning, memory and treatment of adult diseases.
We aim to engage aficionados as well as those interested in learning more about how to implement these approaches in their own research.
Keywords: Biocatalysis, carbohydrates, glycans, glycoscience, synthesis, recognition.
Who should attend: Anyone interested in the recent advances in the synthesis, roles and applications of glycans and glycoconjugates.
Theme song: “Watermelon Sugar” by Harry Styles.
This session is powered by a sugar rush.
Speakers
Synthesis of glycans for exploring their role in health and disease
Xi Chen (chair), University of California, Davis
Catherine L. Grimes, University of Delaware
Rita Gerardy–Schahn, Hannover Medical School
Steven D. Townsend, Vanderbilt University
Jerry Troutman, University of North Carolina at Charlotte
Chemical glycobiology and tools for glycoscience
Catherine Grimes (chair), University of Delaware
Mireille Kamariza, Harvard University
Jeff Gildersleeve, National Cancer Institute
Lingjun Li, University of Wisconsin
Tania Lupoli, New York University
Carbohydrate biocatalysts and glycan-binding probes/materials
Catherine Grimes (chair), University of Delaware
Xi Chen, University of California, Davis
Barbara Imperiali, Massachuetts Institute of Technology
Kelley Moremen, University of Georgia
Vered Padler–Karavani, Tel Aviv University
The complete list
Learn about all 11 symposia planned for Discover BMB 2023:- Protein Machines and Disorder
- Regulation of RNA
- Organelles, Mechanisms and Phase Properties of Cellular Quality Control
- Lipid Dynamics and Signals in Membrane and Protein Structure
- Frontiers in Carbohydrate Synthesis and Recognition
- Bias In, Bias Out in Data Science
- Cell Signaling — New Tools and Emerging Concepts
- Education and Professional Development
- Biochemistry of Elemental Cycling
- Advances in Organismal and Cellular Metabolism
- Artificial Intelligence and Machine Learning in Structural Biology, Drug Design and Systems Biology
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
Building the blueprint to block HIV
Wesley Sundquist will present his work on the HIV capsid and revolutionary drug, Lenacapavir, at the ASBMB Annual Meeting, March 7–10, in Maryland.
Gut microbes hijack cancer pathway in high-fat diets
Researchers at the Feinstein Institutes for Medical Research found that a high-fat diet increases ammonia-producing bacteria in the gut microbiome of mice, which in turn disrupts TGF-β signaling and promotes colorectal cancer.
Mapping fentanyl’s cellular footprint
Using a new imaging method, researchers at State University of New York at Buffalo traced fentanyl’s effects inside brain immune cells, revealing how the drug alters lipid droplets, pointing to new paths for addiction diagnostics.
Designing life’s building blocks with AI
Tanja Kortemme, a professor at the University of California, San Francisco, will discuss her research using computational biology to engineer proteins at the 2026 ASBMB Annual Meeting.
Cholesterol as a novel biomarker for Fragile X syndrome
Researchers in Quebec identified lower levels of a brain cholesterol metabolite, 24-hydroxycholesterol, in patients with fragile X syndrome, a finding that could provide a simple blood-based biomarker for understanding and managing the condition.
How lipid metabolism shapes sperm development
Researchers at Hokkaido University identify the enzyme behind a key lipid in sperm development. The findings reveal how seminolipids shape sperm formation and may inform future diagnostics and treatments for male infertility.